Treace Medical Concepts (TMCI) Change in Receivables (2020 - 2026)

Treace Medical Concepts' Change in Receivables history runs 7 years deep, the most recent figure standing at -$11.7 million for Q1 2026.

• Quarterly Change in Receivables fell 25.79% year-over-year to -$11.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$306000.0 (down 107.25% YoY) and the FY2025 annual result came in at $2.1 million, down 63.25% from the prior year.
• Change in Receivables was -$11.7 million for Q1 2026 at Treace Medical Concepts, down from $9.5 million in the prior quarter.
• Across five years, Change in Receivables topped out at $17.2 million in Q4 2024 and bottomed at -$11.7 million in Q1 2026.
• A 5-year average of $966588.2 and a median of -$696000.0 in 2025 frame the typical range for Change in Receivables.
• Annual changes were most pronounced in 2023 — Change in Receivables jumped 343.49% — and 2024, when it sank 229.84%.
• Treace Medical Concepts' Change in Receivables stood at $11.1 million in 2022, then grew by 20.95% to $13.4 million in 2023, then gained by 28.09% to $17.2 million in 2024, then slumped by 44.64% to $9.5 million in 2025, then plunged by 222.77% to -$11.7 million in 2026.
• Business Quant data shows TMCI's Change in Receivables at -$11.7 million in Q1 2026, $9.5 million in Q4 2025, and $2.6 million in Q3 2025.